- Home
- applications
- india
- healthcare cloud development enablement services
Healthcare Cloud Development Enablement Services Product Applications In India
10 applications found
Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique where pulses of electromagnetic fields target and interact with specific brain regions. As a non-invasive method, TMS is not associated with the side effects commonly caused by anti-depressants. ...
ByNexstim Plc based in Helsinki, FINLAND
For patients undergoing radiotherapy for brain metastases, it is important to preserve quality of life after a course of therapy. As a non-invasive method, SmartFocus® nTMS mapping is a valuable new tool for radiotherapists to accurately and reliably modify dosing to help preserve motor function and potentially the quality of life of their ...
ByNexstim Plc based in Helsinki, FINLAND
Our solutions help neurosurgeons plan their most delicate surgeries. NBS accurately and reliably determines the location of vital functions in the brain—such as limb movement, language and speech. As a noninvasive method, NBS mapping can be performed before your treatment decision and prior to any ...
ByNexstim Plc based in Helsinki, FINLAND
Nexstim SmartFocus® nTMS mapping offers you the chance to improve outcomes and your patients’ quality of life. The clinical value of using the NBS System with SmartFocus® e-field navigated TMS technology has been firmly established, with over 100 papers on over 4,100 patients published ...
ByNexstim Plc based in Helsinki, FINLAND
At Nexstim we are using decades of scientific research to help alleviate drug-resistant brain diseases and disorders. As the world’s leading company combining TMS with 3D brain imaging, we offer a powerful noninvasive technique for the relief of chronic, refractory neuropathic ...
ByNexstim Plc based in Helsinki, FINLAND
Stempeucel® can reduce inflammation, which allows the tissues around the fistula tract to ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Anti-inflammatory, angiogenic and wound healing properties of MSCs are key to successfully treat patients with ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of Stempeucel® for Global ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Stempeucel® shown anti-inflammatory, immunomodulatory and chondrogenic properties at key stages of ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Phase 3 study assessing the Efficacy and Safety of Stempeucel® in Patients with Moderate to Severe ARDS due to COVID ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA